Answers are grounded in this paper and cite their sources.
Develops a nomogram predicting overall survival in patients with cutaneous T-cell lymphoma, suggesting improved prognostic tools are needed.
The prognosis of cutaneous T-cell lymphoma (CTCL) remains heterogeneous, and clinically applicable prognostic tools are needed. Using population-based Surveillance, Epidemiology, and End Results (SEER) data (2000-2019), we analyzed incidence trends and developed a prognostic nomogram for overall survival. Incidence rates were assessed by joinpoint regression. Patients diagnosed from 2004 to 2010 formed the training cohort (n = 4316), and those from 2011 to 2015 constituted the temporal validation cohort (n = 2875). Multivariable Cox analysis identified independent prognostic factors, which were incorporated into a nomogram predicting 1-, 3- and 5-year overall survival. Among 7191 patients, CTCL incidence increased from 2000 to 2016 [annual percent change (APC) 1.05%] and then declined through 2019 (APC -8.44%). The nomogram integrates 11 variables: age, sex, race, marital status, histological subtype, median household income, TNM stage, prior malignances, surgery, radiation, and chemotherapy. It demonstrated strong discrimination, with time-dependent area under the curve values >0.815 for all timepoints in both cohorts, and good calibration. Based on nomogram-derived scores, patients were stratified into 3 distinct risk groups with significantly different survival (P < .0001). This SEER-based nomogram provides a practical, multivariable tool for risk stratification in CTCL, using routinely available clinical and demographic data. External validation is warranted to confirm its generalisability.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: